While MSF as a whole continues to speak out about situations where political, military, or other concerns are causing or enabling medical emergencies, MSF’s Access Campaign advocated on behalf of patients when it comes to making lifesaving medications and vaccinations more widely availably, and affordable, particularly in developing countries. This means speaking out again restrictive trade agreements and commercial regulations, trying to use medical data gathered by MSF teams in the field to influence international medical debates, and more generally trying to ensure that people, not profits, are the focus of the conversation around access to medicines.
MSF was also a founding partner of the Drugs for Neglected Diseases initiative (DNDi), an organization that brings together academics, researchers, and medical humanitarian groups to develop new drugs that can fill the vacuums left by pharmaceutical companies and governments when it comes to certain diseases.

FAQ category: